This study is looking at whether a standardized Shatavari (Asparagus racemosus) root extract can help women with perimenopausal symptoms. Perimenopause is the time leading up to menopause, often causing irregular periods, hot flashes, and mood changes. Researchers want to see if taking one capsule of Shatavari root extract daily for 12 weeks improves symptoms compared to a placebo (an inactive capsule that looks the same). You might be able to join if you are a woman between 40 and 45 years old, have an intact uterus and ovaries, and have experienced irregular menstrual cycles or missed periods in the past year. The main way they will measure success is by looking at changes in your Menopause Rating Scale (MRS) score over 12 weeks. The study is currently recruiting 60 participants.

Study design

This is a randomized, double-blind, placebo-controlled study, meaning participants will be randomly assigned to receive either Shatavari root extract or a placebo, and neither you nor the researchers will know which you are receiving. It plans to enroll 60 participants.

What's involved

You would take one capsule daily for 12 weeks. Your Menopause Rating Scale (MRS) score will be measured at the beginning, and at weeks 4, 8, and 12.

Compensation

Not stated in the trial record.

Follow-up

Your symptoms will be assessed for 12 weeks after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.